Trading of Cryo-Cell International was halted at 03:53 PM ET due to "LULD Pause" and resumed at 04:00 PM ET.

NYSEAMERICAN:CCEL

Cryo-Cell International (CCEL) Stock Price, News & Analysis

Cryo-Cell International logo
$4.55 -0.30 (-6.19%)
Closing price 04:10 PM Eastern
Extended Trading
$4.44 -0.11 (-2.31%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Cryo-Cell International Stock (NYSEAMERICAN:CCEL)

Advanced

Key Stats

Today's Range
$4.11
▼
$4.72
50-Day Range
$3.53
▼
$5.40
52-Week Range
$2.72
▼
$5.45
Volume
22,061 shs
Average Volume
15,681 shs
Market Capitalization
$36.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cryo-Cell International provides stem cell processing and cryogenic storage services, primarily for families preserving cells collected at childbirth. Its core services include processing and storing umbilical cord blood and cord tissue for potential future medical use.

Founded in 1989, the company is based in Oldsmar, Florida, and is among the early private cord blood banking businesses in the United States. It serves customers in the U.S. and reaches international markets through distribution relationships.

Cryo-Cell has also offered services to preserve stem cells from menstrual blood. Its business centers on collecting, processing and storing biological samples rather than providing medical treatment.

AI Generated. May Contain Errors.

Cryo-Cell International Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
3rd Percentile Overall Score

CCEL MarketRank™: 
0.150450689285 of 5 stars

Cryo-Cell International scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Cryo-Cell International.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cryo-Cell International is -19.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cryo-Cell International is -19.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.25% of the float of Cryo-Cell International has been sold short.
  • Short Interest Ratio / Days to Cover

    Cryo-Cell International has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cryo-Cell International has recently increased by 70.79%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Cryo-Cell International does not currently pay a dividend.

  • Dividend Growth

    Cryo-Cell International does not have a long track record of dividend growth.

  • News Sentiment

    Cryo-Cell International has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Cryo-Cell International this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Cryo-Cell International insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    39.93% of the stock of Cryo-Cell International is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    10.44% of the stock of Cryo-Cell International is held by institutions.

  • Read more about Cryo-Cell International's insider trading history.
Receive CCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CCEL Stock News Headlines

Your Copy is on Hold (Claim it now)
James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play. He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60. Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date.tc pixel
See More Headlines

CCEL Stock Analysis - Frequently Asked Questions

Cryo-Cell International's stock was trading at $3.44 at the beginning of 2026. Since then, CCEL shares have increased by 29.2% and is now trading at $4.4450.

Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) issued its quarterly earnings results on Friday, October, 9th. The company reported $0.16 EPS for the quarter. The firm had revenue of $7.82 million for the quarter.

Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cryo-Cell International investors own include Advanced Micro Devices (AMD), Walt Disney (DIS), GE Aerospace (GE), Jumia Technologies (JMIA), Netflix (NFLX), NVIDIA (NVDA) and Vertex Pharmaceuticals (VRTX).

Company Calendar

Last Earnings
10/09/2026
Today
11/16/2026
Fiscal Year End
11/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NYSEAMERICAN:CCEL
CIK
862692
Employees
76
Year Founded
1989

Profitability

EPS (Trailing Twelve Months)
($1.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.43 million
Net Margins
-6.25%
Pretax Margin
-6.13%
Return on Equity
N/A
Return on Assets
-3.17%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.86
Quick Ratio
0.82

Sales & Book Value

Annual Sales
$31.57 million
Price / Sales
1.16
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.31) per share
Price / Book
-1.97

Miscellaneous

Outstanding Shares
8,060,000
Free Float
4,843,000
Market Cap
$36.67 million
Optionable
Not Optionable
Beta
0.45

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NYSEAMERICAN:CCEL) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners